Single Fraction versus Multiple Fraction Radiotherapy for treatment of painful bone metastases: A Prospective Study; Mansoura experience

[1] Agarawal JP, Swangsilpa T, van der Linden Y, Rades D, Jeremic B, Hoskin PJ. The role of external beam radiotherapy in the management of bone metastases. Clin Oncol (R Coll Radiol) 2006; 18:747-60.10.1016/j.clon.2006.09.007Search in Google Scholar

[2] Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy a systematic review of randomised trials. Clin Oncol (R Coll Radiol).2003; 15(6):345-352.10.1016/S0936-6555(03)00113-4Search in Google Scholar

[3] Chow E, Zeng L, Salvo N, Dennis K, Tsao M, Lutz S. Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol (R Coll Radiol). 2012; 24(2):112-124..10.1016/j.clon.2011.11.004Search in Google Scholar

[4] Bone Pain Trial Working Party. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomized comparison with a multifraction schedule over 12 months of patient follow-up. Radiotherapy Oncol 1999; 52:111-21.10.1016/S0167-8140(99)00097-3Search in Google Scholar

[5] Wu JS, Wong R, Johnston M, Bezjak A, Whelan T, on behalf of the Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group. Metaanalysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 2003; 55:594-605.10.1016/S0360-3016(02)04147-0Search in Google Scholar

[6] Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol. 2007; 25(11):1423-1436.10.1200/JCO.2006.09.5281Search in Google Scholar

[7] McQuay HJ, Collins SL, Carroll D, Moore RA. Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev. 2000;(2):CD001793.10.1002/14651858.CD001793Search in Google Scholar

[8] Chow E, Danjoux C, Wong R, et al. Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists. Radiotherapy Oncol 2000; 56:305-14.10.1016/S0167-8140(00)00238-3Search in Google Scholar

[9] Ben-Josef E, Shamsa F, Williams AO, Porter AT. Radiotherapeutic management of osseous metastases: a survey of current patterns of care. Int J Radiat Oncol Biol Phys 1998; 40:915-21.10.1016/S0360-3016(97)00927-9Search in Google Scholar

[10] Roos DE. Continuing reluctance to use single fractions of radiotherapy for metastatic bone pain: an Australian and New Zealand practice survey and literature review. Radiother Oncol 2000; 56:315-22.10.1016/S0167-8140(00)00250-4Search in Google Scholar

[11] Steenland E, Leer JW, van Houwelingen H, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiotherapy Oncol 1999; 52:101-9.10.1016/S0167-8140(99)00110-3Search in Google Scholar

[12] Hartsell WF, Scott CB, Bruner DW, et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 2005; 97:798-804.10.1093/jnci/dji139Search in Google Scholar

[13] Kirkbride P, Warde P, Panzarella T, Aslanidis J, McKenzie M, Sun A. A randomized trial comparing the efficacy of a single radiation fraction with fractionated radiation therapy in the palliation of skeletal metastases [abstract]. Int J Radiat Oncol Biol Phys 2000; 48(suppl):185.10.1016/S0360-3016(00)80164-9Search in Google Scholar

[14] Roos DE, Turner SL, O’Brien PC, Smith JG, Spry NA, Burmeister BH, et al. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans- Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 2005; 75:54-63.10.1016/j.radonc.2004.09.017Search in Google Scholar

[15] Ben-Josef E, Shamsa F, Williams AO, Porter AT. Radiotherapeutic management of osseous metastases: A survey of current patterns of care. Int J Radiat Oncol Biol Phys 1998; 40:915-21.10.1016/S0360-3016(97)00927-9Search in Google Scholar

[16] Haddad P, Wong RK, Pond GR, Soban F, Williams D, McLean M, et al. Factors influencing the use of single vs. multiple fractions of palliative radiotherapy for bone metastases: A 5-year review. Clin Oncol (R Coll Radiol) 2005; 17:430-4.10.1016/j.clon.2005.03.012Search in Google Scholar

[17] Chow E, Lutz S, Beyene J. A single fraction for all, or an argument for fractionation tailored to fit the needs of each individual patient with bone metastases? Int J Radiat Oncol Biol Phys 2003; 55:565-7.10.1016/S0360-3016(02)04148-2Search in Google Scholar

[18] Majumder D, Chatterjee D, Bandyopadhyay A, et al. Single Fraction versus Multiple Fraction Radiotherapy for Palliation of Painful Vertebral Bone Metastases: A Prospective Study Indian Journal of Palliative Care 2014;Vol-18 / Issue3:202-20610.4103/0973-1075.105691Search in Google Scholar

[19] Fairchild A, Barnes E, Ghosh S, et al. International patterns of practice in palliative radiotherapy for painful bone metastases: evidence based practice? Int J Radiat Oncol Biol Phys 2009;75:1281-1628.10.1016/j.ijrobp.2008.12.084Search in Google Scholar

[20] Janjan N, Lutz S, Bedwinek J, et al. Therapeutic guidelines for the treatment of bone metastasis: A report from the American College of Radiology Appropriateness Criteria Expert Panel on Radiation Oncology. J Palliative Medicine 2009; 12:417-42610.1089/jpm.2009.9633Search in Google Scholar

[21] Konski A, James J, Hartsell W, et al. Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastases. Am J Clin Oncol.200 9; 32(4):423-428.10.1097/COC.0b013e31818da9f7Search in Google Scholar

[22] Pollicino CA, Turner SL, Roos DE, O’Brien PC. Costing the components of pain management: analysis of Trans-Tasman Radiation Oncology Group trial (TROG 96.05): one versus five fractions for neuropathic bone pain. Radiother Oncol. 2005; 76(3):264-269.10.1016/j.radonc.2005.07.003Search in Google Scholar

[23] Van den Hout WB, van der Linden YM, Steenland E, et al. Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. J Natl Cancer Inst. 2003; 95(3):222-229.10.1093/jnci/95.3.222Search in Google Scholar

[24] Konski A. Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer. Int J Rad Oncol Biol Phys. 2004;60(5):1373-1378.10.1016/j.ijrobp.2004.05.053Search in Google Scholar